Moderna's stock jumps as health officials say virus vaccine development has 'no glitches'

Shares of Moderna Inc. gained 12% in trading on Friday after a U.S. health official said during a news conference that the use of Moderna's platform in coronavirus vaccine development had "no glitches" so far.